Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Wester

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Journal of Internal Medicine|April 4, 2022
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort studyAxel Wester, Hannes Hagström
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 18, 2022
ReplyAxel Wester, Hannes Hagström
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2022
Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort StudyAxel Wester, Nelson Ndegwa, Hannes Hagström
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2024
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based studyAxel Wester, Peter Jepsen, Hannes Hagström
Scandinavian Journal of Gastroenterology|March 9, 2023
Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patientsHanne Åström, Axel Wester, Hannes Hagström
Journal of Hepatology|May 22, 2025
Reply to "Improving risk estimation in MASLD: Competing events and liver function reserve"Axel Wester, Gabriel Issa, Hannes Hagström
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2022
Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based StudyAxel Wester, Fredrik Åberg, Rupesh Rajani, et al.
Hepatology Communications|September 27, 2023
Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort studyAxel Wester, Ying Shang, Per Stål, et al.
Scandinavian Journal of Gastroenterology|March 16, 2022
Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)Hannes Hagström, Ying Shang, Axel Wester, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2024
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depressionHanne Åström, Ying Shang, Hannes Hagström, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Journal of Internal Medicine|April 4, 2022
Risk of fractures and subsequent mortality in non-alcoholic fatty liver disease: A nationwide population-based cohort studyAxel Wester, Hannes Hagström
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 18, 2022
ReplyAxel Wester, Hannes Hagström
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 10, 2022
Risk of Fractures and Subsequent Mortality in Alcohol-Related Cirrhosis: A Nationwide Population-Based Cohort StudyAxel Wester, Nelson Ndegwa, Hannes Hagström
Liver International : Official Journal of the International Association for the Study of the Liver|April 23, 2024
Statin initiation after myocardial infarction in patients with alcohol-related liver disease: A nationwide population-based studyAxel Wester, Peter Jepsen, Hannes Hagström
Scandinavian Journal of Gastroenterology|March 9, 2023
Administrative coding for non-alcoholic fatty liver disease is accurate in Swedish patientsHanne Åström, Axel Wester, Hannes Hagström
Journal of Hepatology|May 22, 2025
Reply to "Improving risk estimation in MASLD: Competing events and liver function reserve"Axel Wester, Gabriel Issa, Hannes Hagström
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2022
Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based StudyAxel Wester, Fredrik Åberg, Rupesh Rajani, et al.
Hepatology Communications|September 27, 2023
Time trends in mortality and life expectancy in 22,658 patients hospitalized with alcohol-associated cirrhosis: A nationwide cohort studyAxel Wester, Ying Shang, Per Stål, et al.
Scandinavian Journal of Gastroenterology|March 16, 2022
Cohort profile: decoding the epidemiology of liver disease in Sweden (DELIVER)Hannes Hagström, Ying Shang, Axel Wester, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 1, 2024
Persons with metabolic dysfunction-associated steatotic liver disease are at increased risk of severe depressionHanne Åström, Ying Shang, Hannes Hagström, et al.
Pageof 5